Results

Strongbridge Biopharma plc

03/02/2021 | Press release | Distributed by Public on 03/02/2021 06:34

Strongbridge Biopharma plc Announces Submission of New Drug Application for RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome to the U.S. Food &[...]